JAMJOOM PHARMACEUTICALS FACTORY CO. financial statements, including revenue, expenses, and profit

The total revenue of 4015 for the last quarter is 259.70 M SAR, and it's 20.72% lower compared to the previous quarter. The net income of Q4 24 is 51.60 M SAR.